SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001171843-18-000885
Filing Date
2018-02-05
Accepted
2018-02-05 16:57:30
Documents
5
Period of Report
2018-02-01
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 3.02: Unregistered Sales of Equity Securities
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K f8k_020518.htm 8-K 26301
2 EXHIBIT 1.1 exh_11.htm EX-1.1 173625
3 EXHIBIT 5.1 exh_51.htm EX-5.1 7940
4 EXHIBIT 99.1 exh_991.htm EX-99.1 9337
5 GRAPHIC wilmerhale.jpg GRAPHIC 1774
  Complete submission text file 0001171843-18-000885.txt   221053
Mailing Address 4233 TECHNOLOGY DR DURHAM NC 27704
Business Address 4233 TECHNOLOGY DR DURHAM NC 27704 9192876300
ARGOS THERAPEUTICS INC (Filer) CIK: 0001105533 (see all company filings)

IRS No.: 562110007 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35443 | Film No.: 18574968
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences